Better Therapeutics, Inc. (BTTX) stock remained unchanged at $0.00 a share on NASDAQ. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
Employees | 54 |
Beta | 1.914 |
Sales or Revenue | $0.00 |
5Y Sales Change% | -1% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Better Therapeutics, Inc. (NASDAQ: BTTX) stock price is $0.00 in the last trading session. During the trading session, BTTX stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in BTTX stock occurred in the recent session was 0% while the dollar amount for the price change in BTTX stock was -.
The NASDAQ listed BTTX is part of Biotechnology industry that operates in the broader Healthcare sector. Better Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Frank L. Karbe
Chief Executive Officer, Pres & Director
Ms. Angela Willis
Senior Vice President of Market Access
Ms. Diane Gomez-Thinnes
Chief Commercial Officer
Dr. Mark A. Berman M.D.
Chief Medical Officer
Mr. Kevin J. Appelbaum
Co-Founder & Director
Mr. Thiago Licias De Oliveira
Chief People Officer
Mr. Andres Camacho
Senior Vice President of Technology & Head of Engineering
Mr. David P. Perry M.B.A.
Co-Founder & Executive Chairman
Mr. Mark Heinen
Head of Fin. & Chief Financial Officer
Ms. Kristin Wynholds
Chief Product Officer
BTTX's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.27 is -99.96%.
Number of BTTX employees currently stands at 54.
Official Website of BTTX is: https://www.bettertx.com
BTTX could be contacted at phone 415 887 2311 and can also be accessed through its website. BTTX operates from 548 Market Street, San Francisco, CA 94104, United States.
BTTX stock volume for the day was 3K shares. The average number of BTTX shares traded daily for last 3 months was 14.03K.
The market value of BTTX currently stands at $5.45K with its latest stock price at $0.00 and 54.52M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com